Clinical Trial

A Study Of Synthetic THC And Sleep

Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine if oral dronabinol prior to sleep can improve CPAP adherence and sleep quality in humans. We also seek to determine if combination therapy of CPAP and pre-sleep dronabinol is associated with improved BP regulation. We will also explore BP regulatory mechanisms and whether these are impacted differently between traditional CPAP therapy and combination CPAP/dronabinol.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-30.
Trial Details
NCT Number NCT07570953
Lead Sponsor Mayo Clinic
Conditions Obstructive Sleep Apnea
Enrollment 72 participants
Start Date 2026-09
Primary Completion 2028-04 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2026-08-13